Welcome to our Corporate client solution
Here you can administrate your corporate solutions users.
Your IP is registered with the company mentioned above and provides access to Life Science Focus.
Astrazeneca visar upp en ökad vinst per aktie men väntar sig en minskning under det kommande året.